Join us in building systems that improve themselves across financial markets, healthcare, and legal services
• Series A raises at $60M pre-money valuation
• Your SAFE converts at $20M cap (better than 20% discount)
• $2M investment = 10% of company
At $60M valuation, your 10% = $6M (3x return)
Investing in early-stage companies involves substantial risk. There is no guarantee of return on investment. SAFEs convert to equity only upon a qualified financing event (typically Series A). You may lose your entire investment. This investment is illiquid and there is no established market for resale. Only accredited investors may participate.
Past performance does not guarantee future results. The 72% win rate and other metrics shown are historical results achieved under specific market conditions. Market conditions change and future performance may differ significantly. Trading involves substantial risk of loss. NEXUS's trading capabilities are not financial advice.
NEXUS healthcare applications are NOT FDA approved and are for research and development purposes only. They are not intended for clinical use, diagnosis, or treatment. Always consult qualified medical professionals for health-related decisions.
Only accredited investors may participate in this offering. An accredited investor must have: (1) annual income exceeding $200,000 individually or $300,000 jointly for the past two years with expectation of the same this year, OR (2) net worth exceeding $1,000,000 excluding primary residence. By applying, you certify you meet these requirements.